(Q44844284)

6 December 2017

title

Paroxetine use throughout pregnancy: does it pose any risk to the neonate? (English)

1 reference

6 December 2017

Morag I

1

1 reference

6 December 2017

Batash D

2

1 reference

6 December 2017

Keidar R

3

1 reference

6 December 2017

Bulkowstein M

4

1 reference

6 December 2017

Heyman E

5

1 reference

6 December 2017

publication date

1 January 2004

1 reference

Journal of Toxicology: Clinical Toxicology

6 December 2017

published in

1 reference

6 December 2017

volume

42

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

97-100

1 reference

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Neonatal paroxetine withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Prenatal exposure of rats to antidepressant drugs down-regulates beta-adrenoceptors and 5-HT2 receptors in cerebral cortex. Lack of correlation between 5-HT2 receptors and serotonin-mediated behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Perinatal outcome following third trimester exposure to paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Birth outcomes in pregnant women taking fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Effects of third trimester fluoxetine exposure on the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Paroxetine withdrawal syndrome in a neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

Birth outcomes following prenatal exposure to fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCLT-120028753

21 January 2018

Identifiers

DOI

10.1081/CLT-120028753

1 reference

6 December 2017

1 reference